How has been the historical performance of Asarfi Hospital?
Asarfi Hospital experienced significant financial growth from March 2024 to March 2025, with net sales rising from 84.40 Cr to 120.57 Cr and profit after tax increasing from 4.16 Cr to 10.58 Cr. However, cash flow from operating activities turned negative at -4.00 Cr, despite overall profitability.
Answer:The historical performance of Asarfi Hospital shows significant growth in various financial metrics from March 2024 to March 2025.Breakdown:
Asarfi Hospital's net sales increased from 84.40 Cr in March 2024 to 120.57 Cr in March 2025, reflecting a strong growth trajectory. Total operating income also rose correspondingly, reaching 120.57 Cr in March 2025, up from 84.40 Cr the previous year. The total expenditure, excluding depreciation, increased to 97.01 Cr from 68.35 Cr, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) improved significantly, rising to 31.08 Cr in March 2025 from 17.72 Cr in March 2024, while profit before tax increased to 14.31 Cr from 6.24 Cr. Consequently, profit after tax surged to 10.58 Cr in March 2025, compared to 4.16 Cr in the prior year. The earnings per share (EPS) also saw a notable rise, reaching 5.38 in March 2025 from 2.11 in March 2024. On the balance sheet, total liabilities grew to 163.89 Cr from 154.09 Cr, with total assets also increasing to 163.89 Cr from 154.09 Cr. Cash flow from operating activities, however, turned negative at -4.00 Cr in March 2025, down from 26.00 Cr in March 2024, indicating challenges in cash generation despite the overall profitability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
